Clinical Research Directory
Browse clinical research sites, groups, and studies.
Movement State-dependent Adaptive DBS for PD
Sponsor: Doris Wang, MD, PhD
Summary
This is a single-center clinical study aiming to improve gait functions in patients with Parkinson's Disease (PD) by using adaptive neurostimulation to the pallidum. The investigators will use a bidirectional deep brain stimulation device with sensing and stimulation capabilities to 1) identify neural biomarkers to detect the onset of walking by recording neural activities from the motor cortical areas and the globus pallidus, 2) understand the impacts of changes in DBS parameters on gait kinematics and optimize setting parameters for enhancing walking performance, 3) develop a movement state-dependent adaptive deep brain stimulation (DBS) paradigm to automatically switch stimulation settings according to different movement states (i.e., walking vs non-walking). The proposed therapy will deliver personalized neurostimulation based on individual physiological biomarkers to enhance gait function in patients with PD. 6 patients with idiopathic Parkinson's disease who have already been implanted with the Medtronic Summit RC+S device will be enrolled in this study.
Official title: Movement State-Dependent Adaptive Deep Brain Stimulation for Parkinson's Disease
Key Details
Gender
All
Age Range
21 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2026-02-04
Completion Date
2030-04-01
Last Updated
2026-02-23
Healthy Volunteers
No
Conditions
Interventions
Summit RC+S
Participants receive gait-optimized stimulation settings while walking and Parkinson's disease symptom-optimized settings during non-walking periods.
Summit RC+S
Participants receive clinically-optimized open-loop deep brain stimulation ot the pallidum.
Locations (1)
UCSF
San Francisco, California, United States